Attention subscribers
If you are a current subscriber but do not have an online account, click here to set up your free access.
Not yet a subscriber? click here to subscribe today.
Log in Subscribe

Novo chops Wegovy prices, but doctors still see affordability challenges for patients

Posted 11/17/25

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it …

This item is available in full to subscribers.

Please log in to continue

Log in